NEW YORK (GenomeWeb News) – Accelr8 has granted Schott Technical Glass Solutions a license to sell its OptiChem-coated products for medical diagnostic applications.
The companies also renewed a license to Schott covering the German company's Nexterion microarray slides using OptiChem biocoatings. The renewal extends through Nov. 24, 2014.
The new medical diagnostics deal gives Schott the rights to sell up to 20,000 units of OptiChem-coated products per year to any single customer. If the customer exceeds that figure, Schott will refer the customer to Accelr8 to negotiate a direct license from the Denver-based firm.
Schott is paying Accelr8 a license fee of $150,000 and non-recourse pre-paid royalties. Schott will pay additional cash royalties to Accelr8 after Schott has met cumulative sales that generate the pre-paid royalty amount, the two firms said.
Accelr8 also has a licensing deal with Nanosphere in medical diagnostics.